Evaluation of therapy in acquired porphyria cutanea tarda.
D000249:Adenosine Monophosphate / Q000627:therapeutic use; D000328:Adult; D002614:Chelating Agents / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D006801:Humans; D011164:Porphyrias / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D011732:Pyridoxal Phosphate / Q000627:therapeutic use; D013472:Sunlight; D014680:Veins / Q000601:surgery
D002614:Chelating Agents; D000249:Adenosine Monophosphate; D011732:Pyridoxal Phosphate; D002738:Chloroquine